Prevalence of Cardiovascular Disease and Osteoporosis During Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multicenter, Cross-sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study

Objective To analyze the prevalence of cardiovascular disease (CVD) and osteoporosis in patients treated with androgen deprivation therapy (ADT) for prostate cancer (PCa) but not adherent to European Association of Urology (EAU) guidelines. Materials and Methods The CHOosIng Treatment for Prostate C...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Urology (Ridgewood, N.J.) N.J.), 2016-10, Vol.96, p.165-170
Hauptverfasser:	Morgia, Giuseppe, Russo, Giorgio Ivan, Tubaro, Andrea, Bortolus, Roberto, Randone, Donato, Gabriele, Pietro, Trippa, Fabio, Zattoni, Filiberto, Porena, Massimo, Mirone, Vincenzo, Serni, Sergio, Del Nero, Alberto, Lay, Giancarlo, Ricardi, Umberto, Rocco, Francesco, Terrone, Carlo, Pagliarulo, Arcangelo, Ludovico, Giuseppe, Vespasiani, Giuseppe, Brausi, Maurizio, Simeone, Claudio, Novella, Giovanni, Carmignani, Giorgio, Leonardi, Rosario, Pinnarò, Paola, De Paula, Ugo, Corvò, Renzo, Tenaglia, Raffaele, Siracusano, Salvatore, Mantini, Giovanna, Gontero, Paolo, Savoca, Gianfranco, Ficarra, Vincenzo
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Androgen Antagonists - administration & dosage Androgen Antagonists - adverse effects Cardiovascular Diseases - epidemiology Cardiovascular Diseases - etiology Cross-Sectional Studies Gonadotropin-Releasing Hormone - agonists Humans Male Orchiectomy - adverse effects Osteoporosis - epidemiology Osteoporosis - etiology Prevalence Prostatic Neoplasms - therapy Urology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!